New published peer-reviewed study proves Styku can predict Metabolic Syndrome with 92% Accuracy
Raj Sareen, CEO of Styku, announces a new addition to the company’s academic validation and clinical studies in this recent Linkedin post (shown below). The article being discussed is Three-dimensional… Read More »New published peer-reviewed study proves Styku can predict Metabolic Syndrome with 92% Accuracy